Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „dabigatran“
Suchtreffer
Begriffe & Kennungen
Dabigatran Etexilate Accord · 4.5 Interaction with other medicinal products and other forms of interaction · 2
Eintrag öffnenDabigatran Etexilate Accord · 4.5 Interaction with other medicinal products and other forms of interaction · 3
Eintrag öffnenDabigatran Etexilate Accord · 4.5 · 11 Concomitant use not recommended Tacrolimus has been found in vitro to have a similar level of inhibitory ef
Eintrag öffnenDabigatran Etexilate Accord · 4.5 · 12 Concomitant administration of 90 mg ticagrelor twice a day (maintenance dose) with 110 mg dabigatran etexil
Eintrag öffnenDabigatran Etexilate Accord · 4.5 · 13 unchanged comparing combined treatment and the respective mono -treatments. With a loading dose of 300 mg o
Eintrag öffnenDabigatran Etexilate Accord · 4.5 · 43 Tacrolimus has been found in vitro to have a similar level of inhibitory effect on P gp as that seen with i
Eintrag öffnenDabigatran Etexilate Accord · 4.5 · 44 Posaconazole also inhibits P-gp to some extent but has not been clinically studied. Posaconazole Caution sh
Eintrag öffnenDabigatran Etexilate Accord · 4.5 · 45 Clopidogrel In young healthy male volunteers, the concomitant administration of dabigatran etexilate and cl
Eintrag öffnenDabigatran Etexilate Accord · 4.5 · 83 When dabigatran etexilate (150 mg) was co-administered with oral verapamil, the Cmax and AUC of dabigatran
Eintrag öffnenDabigatran Etexilate Accord · 4.5 · 84 Concomitant use should be avoided. Concomitant administration is expected to result in decreased dabigatran
Eintrag öffnenDabigatran Etexilate Accord · 4.5 · 85 increase the risk for any bleeding from 12 % to 18 % and 24 % with 81 mg and 325 mg ASA, respectively (see
Eintrag öffnenDabigatran Etexilate Accord · 4.5 · Anticoagulants and antiplatelet aggregation medicinal products
Eintrag öffnenDabigatran Etexilate Accord · 4.5 · Anticoagulants and antiplatelet aggregation medicinal products
Eintrag öffnenDabigatran Etexilate Accord · 4.5 · Anticoagulants and antiplatelet aggregation medicinal products
Eintrag öffnenDabigatran Etexilate Accord · 4.5 · Concomitant administration of 90 mg ticagrelor twice a day (maintenance dose) with 110 mg dabigatran etexilate
Eintrag öffnenDabigatran Etexilate Accord · 4.5 · Concomitant administration of 90 mg ticagrelor twice a day (maintenance dose) with 110 mg dabigatran etexilate
Eintrag öffnenDabigatran Etexilate Accord · 4.5 · Concomitant administration of a loading dose of 180 mg ticagrelor and 110 mg Ticagrelor dabigatran etexilate (
Eintrag öffnenDabigatran Etexilate Accord · 4.5 · Concomitant administration of a loading dose of 180 mg ticagrelor and 110 mg dabigatran etexilate (in steady s
Eintrag öffnenDabigatran Etexilate Accord · 4.5 · Concomitant administration of a loading dose of 180 mg ticagrelor and 110 mg dabigatran etexilate (in steady s
Eintrag öffnenDabigatran Etexilate Accord · 4.5 · Concomitant use contraindicated (see section 4.3) Ketoconazole increased total dabigatran AUC 0-∞ and Cmax val
Eintrag öffnen